Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Persistent Headache in Patients With Multiple Sclerosis Starting Treatment With Fingolimod.
Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis.
Promoting peripheral myelin repair.
Neuromyelitis optica spectrum disorder in a patient with Kikuchi-Fujimoto disease.
Animal modeling an oligodendrogliopathy - multiple system atrophy.
Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.
Tellurium Compound AS101 Ameliorates Experimental Autoimmune Encephalomyelitis by VLA-4 Inhibition and Suppression of Monocyte and T Cell Infiltration into the CNS.
Correction: Predicting Relapsing-Remitting Dynamics in Multiple Sclerosis Using Discrete Distribution Models: A Population Approach.
LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in experimental autoimmune encephalomyelitis mice.
Cardiovascular Dysfunction in Multiple Sclerosis.
Similar barriers and facilitators to physical activity across different clinical groups experiencing lower limb spasticity.
Ozone Therapy in Ethidium Bromide-Induced Demyelination in Rats: Possible Protective Effect.
Magnetization transfer ratio recovery in new lesions decreases during adolescence in pediatric-onset multiple sclerosis patients.
Activation of endogenous neural stem cells for multiple sclerosis therapy.
Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis.
Resolution of Acute Disseminated Encephalomyelitis Following Termination of Pregnancy.
Management of faecal incontinence and constipation in adults with central neurological diseases.
TGF-beta1 regulates human brain pericyte inflammatory processes involved in neurovasculature function.
Neuromyelitis optica: Contribution of therapeutic responses markers monitoring in patients given rituximab.
[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action].
Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients.
Erratum to: Reassessing the risk of natalizumab-associated PML.
There is no evidence to support or refute the effectiveness of memory rehabilitation on memory function or functional abilities in people with multiple sclerosis.
Does Physical Activity Change Over 24 Months in Persons With Relapsing-Remitting Multiple Sclerosis?

Pages